Analysts’ Viewpoint
Rise in patient safety concerns and increase in demand for safer and more reliable pyrogen testing methods in end-use industries such as pharmaceutical, biotechnology, medical devices, and cosmetics are driving the global monocyte activation test market. MAT's appeal as an alternative to traditional animal-based pyrogen testing lies in its higher sensitivity and specificity, including its ability to detect non-endotoxin pyrogens. Growth in the global healthcare sector is also fueling the monocyte activation test market demand.
Governments and regulatory agencies worldwide have recognized MAT's importance in ensuring product safety and efficacy, leading to its widespread integration into manufacturing and testing processes. Key players are focusing on expanding their product portfolios, optimizing MAT assays, and collaborating with regulatory bodies to obtain necessary approvals. This is creating value-grab monocyte activation test market opportunities for industry participants.
Monocyte activation test (MAT) is an in vitro assay used to detect and quantify the presence of pyrogens in pharmaceuticals, medical devices, and other healthcare products. Pyrogens are substances that can induce fever when introduced into the human body and pose a significant risk to patient safety.
MAT assesses the ability of test substances to activate human monocytes, a type of white blood cell. Monocytes trigger the release of pro-inflammatory cytokines, such as interleukin-1 beta (IL-1β) and tumor necrosis factor-alpha (TNF-α), when exposed to pyrogens. These cytokines are indicative of a pyrogenic response, mimicking what would happen in the human body if exposed to pyrogen.
Demand for MAT in drug development is likely to increase in the near future, owing to the rise in need for maintaining patient safety. Ethical aspect of MAT is one of the primary reasons for the increase in demand for the test. The usage of live animals, such as rabbits in the rabbit pyrogen test, raises ethical concerns regarding animal welfare and unnecessary suffering. The shift toward more ethical testing practices aligns with societal values and reflects the growing emphasis on responsible R&D in the healthcare sector.
Increase in focus on ethical testing practices and regulatory acceptance of MAT as a validated method for pyrogen testing further support the adoption of the test among drug development companies.
MAT also offers other advantages over traditional pyrogen testing methods. These tests are more sensitive and specific. This helps detect a broader range of pyrogens, including non-endotoxin pyrogens, which may be missed by animal-based tests.
Advances in technology have played a crucial role in enhancing the monocyte activation test (MAT) methods in various industries. Continuous innovations in test offerings and MAT assays have led to improvements in sensitivity, specificity, and reproducibility, making it a reliable and efficient method for detecting pyrogens.
Refinement of assay procedures is one of the key areas of technological advancements in MAT. Researchers are focusing upon optimizing the process of activating monocytes and measuring the release of pro-inflammatory cytokines accurately. This has resulted in increased sensitivity, thus allowing MAT to detect even lower levels of pyrogens that might be missed by traditional pyrogen testing methods.
Advancements in assay techniques have led to improved specificity in differentiating between different types of pyrogens. MAT can now detect and distinguish between endotoxin pyrogens (such as lipopolysaccharides - LPS) and non-endotoxin pyrogens (NEPs) with higher precision. This specificity is crucial in identifying the exact nature of pyrogenic contaminants and ensuring appropriate actions are taken to mitigate risks.
Technological advancements have facilitated the automation and high-throughput capabilities of MAT, allowing for faster and more efficient testing processes. Automated MAT platforms enhance productivity, reduce turnaround times, and increase the overall efficiency of quality control operations in pharmaceutical and medical device industries.
Integration of advanced data analysis techniques and machine learning algorithms has also contributed to market development. These approaches help in better interpretation of test results, identifying patterns, and optimizing the assay parameters to enhance overall performance.
In terms of product type, the global market has been bifurcated into MAT kits and reagents. The MAT kits product type segment accounted for the largest market share in 2022. It is anticipated to dominate the global landscape during the forecast period.
MAT kits are pre-packaged assay kits that contain all the necessary reagents and components required to perform the test. These kits offer several advantages, including convenience, standardization, and ease of use, making them a preferred choice for laboratories and researchers.
MAT kits ensure consistent and reproducible test results. Hence, they are used in pharmaceutical, medical device, and cosmetics industries for quality control purposes.
PBMCs (peripheral blood mononuclear cells) are white blood cells commonly used in MAT to assess the activation of monocytes when exposed to pyrogens. These cells play a crucial role in the innate immune response, making them a reliable source for detecting pyrogenic reactions.
PBMCs offer greater sensitivity and specificity, thus enabling the detection of a wide range of pyrogens, which might be missed by other sources. Furthermore, PBMCs are readily available and can be obtained from peripheral blood samples. They simplify the testing process and reduce the need for invasive procedures.
In terms of end-user, the pharmaceutical industry end-user segment held significant market share in 2022. It is anticipated to lead the global market in the near future.
The pharmaceutical industry relies on monocyte activation tests to ensure the safety and efficacy of their products before commercialization. MAT can accurately detect a wide range of pyrogens, including non-endotoxin pyrogens, in the pharmaceutical sector.
Increase in regulatory acceptance and validation of MAT as a recognized method for pyrogen testing have further bolstered its adoption in the pharmaceutical industry. Demand for MAT is expected to remain high in the near future due to growth in the pharmaceutical sector and rise in patient safety concerns.
Growth of the pharmaceutical industry end-user segment can also be ascribed to the continuous advancements in technology and the pharmaceutical industry's unwavering commitment to quality.
According to the monocyte activation test market research analysis, North America accounted for significant share of the global landscape in 2022. The region is estimated to dominate during the forecast period.
North America, comprising the U.S. and Canada, is a key region for MAT adoption, led by the presence of well-established pharmaceutical and medical device industries. Furthermore, increase in focus on patient safety and quality control is fueling the monocyte activation test market growth in the region.
Rise in demand for ethical and reliable pyrogen testing methods is augmenting the market statistics in North America. Regulatory acceptance of MAT by organizations such as the United States Pharmacopeia (USP) and the Government of Canada has further supported its integration into industry practices in the region.
The monocyte activation test market size in Asia Pacific is projected to increase during the forecast period, owing to the growth in pharmaceutical and healthcare industries in the region. China, India, Japan, South Korea, and Australia are witnessing high adoption of MAT for pyrogen testing.
Advancements in technology and growth in awareness about MAT's advantages have further bolstered the popularity of the test in Asia Pacific. Increase in investment in improving the healthcare infrastructure is also augmenting the market progress in the region.
The global landscape is fragmented, with the presence of a few companies that control majority of the monocyte activation test market share. Companies are implementing innovative strategies such as R&D, mergers, and acquisitions to gain incremental opportunities.
Merck KGaA, Charles River Laboratories International, Inc., Thermo Fisher Scientific, Sanquin, Becton, Dickinson and Company, Microcoat Biotechnologie GmbH, SOLVIAS AG, and Lonza Group are some of the key players in the monocyte activation test market. These players are following the latest monocyte activation test market trends to avail lucrative revenue opportunities.
Key players have been profiled in the monocyte activation test market forecast report based on parameters such as company overview, financial overview, business strategies, product portfolio, business segments, and latest developments.
| Attribute | Detail |
|---|---|
|
Market Size in 2022 |
US$ 60.7 Mn |
|
Market Forecast Value in 2031 |
More than US$ 305.3 Mn |
|
Growth Rate (CAGR) |
19.8% |
|
Forecast Period |
2023-2031 |
|
Historical Data Available for |
2017-2021 |
|
Quantitative Units |
US$ Mn for Value |
|
Market Analysis |
It includes segment analysis as well as regional level analysis. Moreover, qualitative analysis includes drivers, restraints, opportunities, key trends, Porter’s Five Forces analysis, value chain analysis, and key trend analysis. |
|
Competition Landscape |
|
|
Format |
Electronic (PDF) + Excel |
|
Market Segmentation |
|
|
Regions Covered |
|
|
Countries Covered |
|
|
Companies Profiled |
|
|
Customization Scope |
Available upon request |
|
Pricing |
Available upon request |
It was valued at US$ 60.7 Mn in 2022
It is projected to reach more than US$ 305.3 Mn by 2031
The CAGR is anticipated to be 19.8% from 2023 to 2031
Rise in patient safety concerns and increase in demand for safer and more reliable pyrogen testing methods in end-use industries
The MAT kits product type segment held the leading share in 2022
North America is expected to account for the leading share from 2023 to 2031
Merck KGaA, Thermo Fisher Scientific, Charles River Laboratories International, Inc., Sanquin, Microcoat Biotechnologie GmbH, Becton, Dickinson and Company, SOLVIAS AG, and Lonza Group
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Monocyte Activation Test Market
4. Market Overview
4.1. Introduction
4.1.1. Product Definition
4.1.2. Industry Evolution / Development
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Monocyte Activation Test Market Analysis and Forecast, 2017-2031
5. Key Insights
5.1. Advancement in Pyrogen Tests
5.2. Healthcare Industry Overview
5.3. COVID-19 Pandemic Impact on Industry (Value Chain and Short/Mid/Long Term Impact)
5.4. Technological Advancements
6. Global Monocyte Activation Test Market Analysis and Forecast, by Product Type
6.1. Introduction & Definition
6.2. Key Findings/Developments
6.3. Market Value Forecast, by Product Type, 2017-2031
6.3.1. MAT Kits
6.3.2. Reagents
6.4. Market Attractiveness Analysis, by Product Type
7. Global Monocyte Activation Test Market Analysis and Forecast, by Source
7.1. Introduction & Definition
7.2. Key Findings/Developments
7.3. Market Value Forecast, by Source, 2017-2031
7.3.1. PBMC Based
7.3.2. Cell Line Based
7.4. Market Attractiveness Analysis, by Source
8. Global Monocyte Activation Test Market Analysis and Forecasts, by Application
8.1. Introduction & Definition
8.2. Key Findings/Developments
8.3. Market Value Forecast, by Application, 2017-2031
8.3.1. Drug Development
8.3.2. Vaccine Development
8.3.3. Medical Device Testing
8.3.4. Others (Research, etc.)
8.4. Market Attractiveness Analysis, by Application
9. Global Monocyte Activation Test Market Analysis and Forecast, by End-user
9.1. Introduction & Definition
9.2. Key Findings/Developments
9.3. Market Value Forecast, by End-user, 2017-2031
9.3.1. Pharmaceutical Industry
9.3.2. Biotechnology Industry
9.3.3. Medical Device Industry
9.3.4. Others (CROs, Academic & Research Institute, etc.)
9.4. Market Attractiveness Analysis, by End-user
10. Global Monocyte Activation Test Market Analysis and Forecast, by Region
10.1. Key Findings
10.2. Market Value Forecast, by Region, 2017-2031
10.2.1. North America
10.2.2. Europe
10.2.3. Asia Pacific
10.2.4. Latin America
10.2.5. Middle East & Africa
10.3. Market Attractiveness By Country/Region
11. North America Monocyte Activation Test Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Product Type, 2017-2031
11.2.1. MAT Kits
11.2.2. Reagents
11.3. Market Value Forecast, by Source, 2017-2031
11.3.1. PBMC Based
11.3.2. Cell Line Based
11.4. Market Value Forecast, by Application, 2017-2031
11.4.1. Drug Development
11.4.2. Vaccine Development
11.4.3. Medical Device Testing
11.4.4. Others (Research, etc.)
11.5. Market Value Forecast, by End-user, 2017-2031
11.5.1. Pharmaceutical Industry
11.5.2. Biotechnology Industry
11.5.3. Medical Device Industry
11.5.4. Others (CROs, Academic & Research Institute, etc.)
11.6. Market Value Forecast, by Country/Sub-region, 2017-2031
11.6.1. U.S.
11.6.2. Canada
11.7. Market Attractiveness Analysis
11.7.1. By Product Type
11.7.2. By Source
11.7.3. By Application
11.7.4. By End-user
11.7.5. By Country/Sub-region
12. Europe Monocyte Activation Test Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Product Type, 2017-2031
12.2.1. MAT Kits
12.2.2. Reagents
12.3. Market Value Forecast, by Source, 2017-2031
12.3.1. PBMC Based
12.3.2. Cell Line Based
12.4. Market Value Forecast, by Application, 2017-2031
12.4.1. Drug Development
12.4.2. Vaccine Development
12.4.3. Medical Device Testing
12.4.4. Others (Research, etc.)
12.5. Market Value Forecast, by End-user, 2017-2031
12.5.1. Pharmaceutical Industry
12.5.2. Biotechnology Industry
12.5.3. Medical Device Industry
12.5.4. Others (CROs, Academic & Research Institute, etc.)
12.6. Market Value Forecast, by Country/Sub-region, 2017-2031
12.6.1. Germany
12.6.2. U.K.
12.6.3. France
12.6.4. Italy
12.6.5. Spain
12.6.6. Rest of Europe
12.7. Market Attractiveness Analysis
12.7.1. By Product Type
12.7.2. By Source
12.7.3. By Application
12.7.4. By End-user
12.7.5. By Country/Sub-region
13. Asia Pacific Monocyte Activation Test Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Product Type, 2017-2031
13.2.1. MAT Kits
13.2.2. Reagents
13.3. Market Value Forecast, by Source, 2017-2031
13.3.1. PBMC Based
13.3.2. Cell Line Based
13.4. Market Value Forecast, by Application, 2017-2031
13.4.1. Drug Development
13.4.2. Vaccine Development
13.4.3. Medical Device Testing
13.4.4. Others (Research, etc.)
13.5. Market Value Forecast, by End-user, 2017-2031
13.5.1. Pharmaceutical Industry
13.5.2. Biotechnology Industry
13.5.3. Medical Device Industry
13.5.4. Others (CROs, Academic & Research Institute, etc.)
13.6. Market Value Forecast, by Country/Sub-region, 2017-2031
13.6.1. China
13.6.2. Japan
13.6.3. India
13.6.4. Australia & New Zealand
13.6.5. Rest of Asia Pacific
13.7. Market Attractiveness Analysis
13.7.1. By Product Type
13.7.2. By Source
13.7.3. By Application
13.7.4. By End-user
13.7.5. By Country/Sub-region
14. Latin America Monocyte Activation Test Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast, by Product Type, 2017-2031
14.2.1. MAT Kits
14.2.2. Reagents
14.3. Market Value Forecast, by Source, 2017-2031
14.3.1. PBMC Based
14.3.2. Cell Line Based
14.4. Market Value Forecast, by Application, 2017-2031
14.4.1. Drug Development
14.4.2. Vaccine Development
14.4.3. Medical Device Testing
14.4.4. Others (Research, etc.)
14.5. Market Value Forecast, by End-user, 2017-2031
14.5.1. Pharmaceutical Industry
14.5.2. Biotechnology Industry
14.5.3. Medical Device Industry
14.5.4. Others (CROs, Academic & Research Institute, etc.)
14.6. Market Value Forecast, by Country/Sub-region, 2017-2031
14.6.1. Brazil
14.6.2. Mexico
14.6.3. Rest of Latin America
14.7. Market Attractiveness Analysis
14.7.1. By Product Type
14.7.2. By Source
14.7.3. By Application
14.7.4. By End-user
14.7.5. By Country/Sub-region
15. Middle East & Africa Monocyte Activation Test Market Analysis and Forecast
15.1. Introduction
15.1.1. Key Findings
15.2. Market Value Forecast, by Product Type, 2017-2031
15.2.1. MAT Kits
15.2.2. Reagents
15.3. Market Value Forecast, by Source, 2017-2031
15.3.1. PBMC Based
15.3.2. Cell Line Based
15.4. Market Value Forecast, by Application, 2017-2031
15.4.1. Drug Development
15.4.2. Vaccine Development
15.4.3. Medical Device Testing
15.4.4. Others (Research, etc.)
15.5. Market Value Forecast, by End-user, 2017-2031
15.5.1. Pharmaceutical Industry
15.5.2. Biotechnology Industry
15.5.3. Medical Device Industry
15.5.4. Others (CROs, Academic & Research Institute, etc.)
15.6. Market Value Forecast, by Country/Sub-region, 2017-2031
15.6.1. GCC Countries
15.6.2. South Africa
15.6.3. Rest of Middle East & Africa
15.7. Market Attractiveness Analysis
15.7.1. By Product Type
15.7.2. By Source
15.7.3. By Application
15.7.4. By End-user
15.7.5. By Country/Sub-region
16. Competition Landscape
16.1. Market Player - Competition Matrix (By Tier and Size of Companies)
16.2. Market Share Analysis, by Company (2021)
16.3. Company Profiles
16.3.1. Merck KGaA
16.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.1.2. Product Portfolio
16.3.1.3. Financial Overview
16.3.1.4. SWOT Analysis
16.3.1.5. Strategic Overview
16.3.2. Thermo Fisher Scientific
16.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.2.2. Product Portfolio
16.3.2.3. Financial Overview
16.3.2.4. SWOT Analysis
16.3.2.5. Strategic Overview
16.3.3. Charles River Laboratories International, Inc.
16.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.3.2. Product Portfolio
16.3.3.3. Financial Overview
16.3.3.4. SWOT Analysis
16.3.3.5. Strategic Overview
16.3.4. Sanquin
16.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.4.2. Product Portfolio
16.3.4.3. Financial Overview
16.3.4.4. SWOT Analysis
16.3.4.5. Strategic Overview
16.3.5. Microcoat Biotechnologie GmbH
16.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.5.2. Product Portfolio
16.3.5.3. Financial Overview
16.3.5.4. SWOT Analysis
16.3.5.5. Strategic Overview
16.3.6. SOLVIAS AG
16.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.6.2. Product Portfolio
16.3.6.3. Financial Overview
16.3.6.4. SWOT Analysis
16.3.6.5. Strategic Overview
16.3.7. Lonza Group
16.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.7.2. Product Portfolio
16.3.7.3. Financial Overview
16.3.7.4. SWOT Analysis
16.3.7.5. Strategic Overview
16.3.8. Becton, Dickinson and Company
16.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.8.2. Product Portfolio
16.3.8.3. Financial Overview
16.3.8.4. SWOT Analysis
16.3.8.5. Strategic Overview
List of Tables
Table 01: Global Monocyte Activation Test Market Value (US$ Mn) Forecast, by Product Type, 2017-2031
Table 02: Global Monocyte Activation Test Market Value (US$ Mn) Forecast, by Source, 2017-2031
Table 03: Global Monocyte Activation Test Market Value (US$ Mn) Forecast, by Application, 2017-2031
Table 04: Global Monocyte Activation Test Market Value (US$ Mn) Forecast, by End-user, 2017-2031
Table 05: Global Monocyte Activation Test Market Size (US$ Mn) Forecast, by Region, 2017-2031
Table 06: North America Monocyte Activation Test Market Value (US$ Mn) Forecast, by Country, 2017-2031
Table 07: North America Monocyte Activation Test Market Value (US$ Mn) Forecast, by Product Type, 2017-2031
Table 08: North America Monocyte Activation Test Market Value (US$ Mn) Forecast, by Source, 2017-2031
Table 09: North America Monocyte Activation Test Market Value (US$ Mn) Forecast, by Application, 2017-2031
Table 10: North America Monocyte Activation Test Market Value (US$ Mn) Forecast, by End-user, 2017-2031
Table 11: Europe Monocyte Activation Test Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
Table 12: Europe Monocyte Activation Test Market Value (US$ Mn) Forecast, by Product Type, 2017-2031
Table 13: Europe Monocyte Activation Test Market Value (US$ Mn) Forecast, by Source, 2017-2031
Table 14: Europe Monocyte Activation Test Market Value (US$ Mn) Forecast, by Application, 2017-2031
Table 15: Europe Monocyte Activation Test Market Value (US$ Mn) Forecast, by End-user, 2017-2031
Table 16: Asia Pacific Monocyte Activation Test Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
Table 17: Asia Pacific Monocyte Activation Test Market Value (US$ Mn) Forecast, by Product Type, 2017-2031
Table 18: Asia Pacific Monocyte Activation Test Market Value (US$ Mn) Forecast, by Source, 2017-2031
Table 19: Asia Pacific Monocyte Activation Test Market Value (US$ Mn) Forecast, by Application, 2017-2031
Table 20: Asia Pacific Monocyte Activation Test Market Value (US$ Mn) Forecast, by End-user, 2017-2031
Table 21: Latin America Monocyte Activation Test Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
Table 22: Latin America Monocyte Activation Test Market Value (US$ Mn) Forecast, by Product Type, 2017-2031
Table 23: Latin America Monocyte Activation Test Market Value (US$ Mn) Forecast, by Source, 2017-2031
Table 24: Latin America Monocyte Activation Test Market Value (US$ Mn) Forecast, by Application, 2017-2031
Table 25: Latin America Monocyte Activation Test Market Value (US$ Mn) Forecast, by End-user, 2017-2031
Table 26: Middle East & Africa Monocyte Activation Test Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
Table 27: Middle East & Africa Monocyte Activation Test Market Value (US$ Mn) Forecast, by Product Type, 2017-2031
Table 28: Middle East & Africa Monocyte Activation Test Market Value (US$ Mn) Forecast, by Source, 2017-2031
Table 29: Middle East & Africa Monocyte Activation Test Market Value (US$ Mn) Forecast, by Application, 2017-2031
Table 30: Middle East & Africa Monocyte Activation Test Market Value (US$ Mn) Forecast, by End-user, 2017-2031
List of Figures
Figure 01: Global Monocyte Activation Test Market Size (US$ Mn) and Distribution, by Region, 2022 and 2031
Figure 02: Global Monocyte Activation Test Market Value (US$ Mn) Forecast, 2017-2031
Figure 03: Global Monocyte Activation Test Market Value Share, by Product Type (2022)
Figure 04: Global Monocyte Activation Test Market Value Share, by Source (2022)
Figure 05: Global Monocyte Activation Test Market Value Share, by Application (2022)
Figure 06: Global Monocyte Activation Test Market Value Share, by End-user (2022)
Figure 07: Global Monocyte Activation Test Market Value Share, by Product Type, 2022 and 2031
Figure 08: Global Monocyte Activation Test Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by MAT Kits, 2017-2031
Figure 09: Global Monocyte Activation Test Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Reagents, 2017-2031
Figure 10: Global Monocyte Activation Test Market Attractiveness, by Product Type, 2017-2031
Figure 11: Global Monocyte Activation Test Market Value Share, by Source, 2022 and 2031
Figure 12: Global Monocyte Activation Test Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by PBMC Based, 2017-2031
Figure 13: Global Monocyte Activation Test Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Cell Line Based, 2017-2031
Figure 14: Global Monocyte Activation Test Market Attractiveness, by Source, 2017-2031
Figure 15: Global Monocyte Activation Test Market Value Share, by Application, 2022 and 2031
Figure 16: Global Monocyte Activation Test Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Drug Development, 2017-2031
Figure 17: Global Monocyte Activation Test Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Vaccine Development, 2017-2031
Figure 18: Global Monocyte Activation Test Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Medical Device Testing, 2017-2031
Figure 19: Global Monocyte Activation Test Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Others (Research, etc.), 2017-2031
Figure 20: Global Monocyte Activation Test Market Attractiveness, by Application, 2017-2031
Figure 21: Global Monocyte Activation Test Market Value Share, by End-user, 2022 and 2031
Figure 22: Global Monocyte Activation Test Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Pharmaceutical Industry, 2017-2031
Figure 23: Global Monocyte Activation Test Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Biotechnology Industry, 2017-2031
Figure 24: Global Monocyte Activation Test Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Medical Device Industry, 2017-2031
Figure 25: Global Monocyte Activation Test Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Others, 2017-2031
Figure 26: Global Monocyte Activation Test Market Attractiveness, by End-user, 2017-2031
Figure 27: Global Monocyte Activation Test Market Value Share, by Region, 2022 and 2031
Figure 28: Global Monocyte Activation Test Market Attractiveness, by Region, 2017-2031
Figure 29: North America Monocyte Activation Test Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%) 2017-2031
Figure 30: North America Monocyte Activation Test Market Value Share, by Country, 2022 and 2031
Figure 31: North America Monocyte Activation Test Market Attractiveness, by Country, 2017-2031
Figure 32: North America Monocyte Activation Test Market Attractiveness, by Product Type, 2017-2031
Figure 33: North America Monocyte Activation Test Market Attractiveness, by Application, 2017-2031
Figure 34: North America Monocyte Activation Test Market Attractiveness, by End-user, 2017-2031
Figure 35: Europe Monocyte Activation Test Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2017-2031
Figure 36: Europe Monocyte Activation Test Market Value Share, by Country/Sub-region, 2022 and 2031
Figure 37: Europe Monocyte Activation Test Market Attractiveness, by Country/Sub-region, 2017-2031
Figure 38: Europe Monocyte Activation Test Market Attractiveness, by Product Type, 2017-2031
Figure 39: Europe Monocyte Activation Test Market Attractiveness, by Source, 2017-2031
Figure 40: Europe Monocyte Activation Test Market Attractiveness, by Application, 2017-2031
Figure 41: Europe Monocyte Activation Test Market Attractiveness, by End-user, 2017-2031
Figure 42: Asia Pacific Monocyte Activation Test Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2017-2031
Figure 43: Asia Pacific Monocyte Activation Test Market Value Share, by Country/Sub-region, 2022 and 2031
Figure 44: Asia Pacific Monocyte Activation Test Market Attractiveness, by Country/Sub-region, 2017-2031
Figure 45: Asia Pacific Monocyte Activation Test Market Attractiveness, by Product Type, 2017-2031
Figure 46: Asia Pacific Monocyte Activation Test Market Attractiveness, by Source, 2017-2031
Figure 47: Asia Pacific Monocyte Activation Test Market Attractiveness, by Application, 2017-2031
Figure 48: Asia Pacific Monocyte Activation Test Market Attractiveness, by End-user, 2017-2031
Figure 49: Latin America Monocyte Activation Test Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2017-2031
Figure 50: Latin America Monocyte Activation Test Market Value Share, by Country/Sub-region, 2022 and 2031
Figure 51: Latin America Monocyte Activation Test Market Attractiveness, by Country/Sub-region, 2017-2031
Figure 52: Latin America Monocyte Activation Test Market Attractiveness, by Product Type, 2017-2031
Figure 53: Latin America Monocyte Activation Test Market Attractiveness, by Source, 2017-2031
Figure 54: Latin America Monocyte Activation Test Market Attractiveness, by Application, 2017-2031
Figure 54: Latin America Monocyte Activation Test Market Attractiveness, by End-user, 2017-2031
Figure 56: Middle East & Africa Monocyte Activation Test Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2017-2031
Figure 57: Middle East & Africa Monocyte Activation Test Market Value Share, by Country/Sub-region, 2022 and 2031
Figure 58: Middle East & Africa Monocyte Activation Test Market Attractiveness, by Country/Sub-region, 2017-2031
Figure 59: Middle East & Africa Monocyte Activation Test Market Attractiveness, by Product Type, 2017-2031
Figure 60: Middle East & Africa Monocyte Activation Test Market Attractiveness, by Source, 2017-2031
Figure 61: Middle East & Africa Monocyte Activation Test Market Attractiveness, by Application, 2017-2031
Figure 62: Middle East & Africa Monocyte Activation Test Market Attractiveness, by End-user, 2017-2031
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
Monocyte Activation Test Market
*86 figures and 60 tables includes